Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Safety of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract Surgery [Phase 1]
Phase 1 clinical trial evaluating the safety of the TimoD Sustained-Release Implant in participants with glaucoma or ocular hypertension und…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension [Phase 2]
Phase 2 clinical trial investigating PA5108 ocular implant for primary open-angle glaucoma or ocular hypertension is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing NCX 470 to latanoprost in open-angle glaucoma or ocular hypertension completed with results posted in 2025.
-
FDA approval · 2025-05-27FDA Approved: DORZOLAMIDE AND TIMOLOL — Supplemental Application (Leading Pharma, LLC)
FDA approval of a supplemental application for the dorzolamide and timolol combination ophthalmic solution from Leading Pharma, LLC.
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects [NA]
This clinical trial is investigating neurovascular coupling in glaucoma patients and healthy subjects; recruitment is ongoing.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-05-20FDA Approved: TIMOLOL MALEATE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for timolol maleate from Rising Pharma Holdings, Inc., authorizing changes to an existing generic pr…
-
FDA approval · 2025-05-16FDA Approved: TIMOLOL MALEATE — Supplemental Application (First Nation Group, LLC)
The FDA approved a supplemental application for TIMOLOL MALEATE from First Nation Group, LLC, authorizing a new generic product on the marke…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Intraocular Pressure Measured by a Novel Sensing Contact Lens Versus Tonometry [NA]
This study compares intraocular pressure measurements from a novel sensing contact lens to traditional tonometry, and it is currently not ye…
-
FDA approval · 2025-05-08FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for dorzolamide hydrochloride from Sagent Pharmaceuticals, authorizing this generic drug for lowerin…
-
FDA approval · 2025-04-29FDA Approved: LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION, 0.024% — Original Application (Gland Pharma Limited)
The FDA approved a generic latanoprostene bunod ophthalmic solution, 0.024%, from Gland Pharma Limited under an Original Application. It is …
-
FDA approval · 2025-04-28FDA Approved: PILOCARPINE HYDROCHLORIDE OPHTHALMIC — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved the original application for Pilocarpine Hydrochloride Ophthalmic from Amneal Pharmaceuticals NY LLC, providing a generic p…
-
FDA approval · 2025-04-25FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Supplemental Application (Gland Pharma Limited)
FDA approved a supplemental application for a generic dorzolamide hydrochloride and timolol maleate eye drop from Gland Pharma Limited. The …
-
FDA approval · 2025-04-14FDA Approved: LATANOPROST — Original Application (Micro Labs Limited)
FDA approved latanoprost from Micro Labs Limited through an original application; indicated to reduce intraocular pressure in open-angle gla…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes [Phase 3]
Phase 3 trial comparing Perrigo's glaucoma/ocular hypertension product to an FDA-approved comparator has completed, and results have been po…
-
FDA approval · 2025-03-27FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application from Micro Labs Limited for dorzolamide hydrochloride and timolol maleate ophthalmic solution. This …
-
CLINICAL_TRIALS trial_result · 2025-03-27Clinical Trial Update: OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects [Phase 3]
This document reports the completion of Phase 3 trials of OPC-1085EL for primary open-angle glaucoma and ocular hypertension in Chinese subj…
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive [Phase 4]
A completed Phase 4 clinical trial comparing BRIDIN-plus with Combigan for efficacy and ocular surface in patients with glaucoma or ocular h…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT) [Phase 2]
Phase 2 study evaluating the efficacy and safety of the OTX-TIC travoprost intracameral implant for Open Angle Glaucoma or Ocular Hypertensi…
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: Long-term Outcomes of Glaucoma Surgery in a Real-life Setting: the Agora Registry Study
Long-term, real-world outcomes of glaucoma surgery are reported from the Agora Registry study.
-
FDA approval · 2025-03-17FDA Approved: BIMATOPROST — Original Application (Lifestar Pharma LLC)
FDA approved the original application for Bimatoprost by Lifestar Pharma LLC, granting approval for a generic ophthalmic solution intended t…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Comparative Study of the NIDEK TONOREF III with Predicate Devices [NA]
A completed comparative clinical trial evaluating the NIDEK TONOREF III tonometer against predicate devices for intraocular pressure measure…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China [Phase 3]
Phase III clinical trial in China evaluating a treatment for open-angle glaucoma or ocular hypertension is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: MINIject Global Long-Term Follow-up Study
This is a global long-term follow-up study for the MINIject glaucoma implant, sponsored by iSTAR Medical, in open-angle glaucoma and ocular …
-
FDA approval · 2025-02-25FDA Approved: BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION — Original Application (Leading Pharma, LLC)
FDA approved a generic fixed-dose combination ophthalmic solution of brimonidine tartrate and timolol maleate from Leading Pharma, LLC under…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Long-term Vascular, Functional and Morphological Changes in Glaucoma and Ocular Hypertensive Patients
This entry provides an update on a long-term study evaluating vascular, functional, and morphological changes in patients with glaucoma and …